Advanced search
Publication Cover
Current Medical Research and Opinion Volume 25, 2009 - Issue 5
Submit an article Journal homepage
244
Views
5
CrossRef citations to date
0
Altmetric
Commentary

Change in formulation and its potential clinical and pharmacoeconomic value: example of extended release venlafaxine

Jean-Marc C. Haeusler UCB, Inc., Smyrna, GA, USACorrespondence[email protected]
Pages 1089-1094 | Accepted 02 Mar 2009, Published online: 20 Mar 2009

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jean-Marc C. Haeusler. (2011) Retrospective analysis of the impact of post-approval drug research on utilization of new medicines in the US. Clinical Research and Regulatory Affairs 28:3, pages 74-80.
Read now
Mindy M. Cheng, Rafael Alfonso, Jennie H. Best, Louis P. Garrison, David Bruhn & David L. Veenstra. (2010) The economic value of reducing medication dosing frequency with drug delivery technologies: an evidence assessment. Journal of Medical Economics 13:2, pages 193-202.
Read now

Articles from other publishers (3)

Serdar TORT, Esra KODAN AKÇA, Seval OLĞAÇ, Sinem SAAR, Ayşegül YILDIZ, İlay Sema ÜNAL, Zeliha Duygu ÖZDAL & Fatmanur TUĞCU DEMİRÖZ. (2022) Venlafaksin Hidroklorürün Uzatılmış Salım Yapan Tablet Formülasyonlarının Geliştirilmesi ve DeğerlendirilmesiDevelopment and Evaluation of Sustained Release Tablet Formulations of Venlafaxine Hydrochloride. Sağlık Bilimlerinde Değer 12:1, pages 28-35.
Crossref
Roberto Gomeni, Françoise Bressolle-Gomeni & Maurizio Fava. (2016) Response Surface Analysis and Nonlinear Optimization Algorithm for Maximization of Clinical Drug Performance: Application to Extended-Release and Long-Acting Injectable Paliperidone. The Journal of Clinical Pharmacology 56:10, pages 1296-1306.
Crossref
Hasmukh A. Patel, Sunil Shah, Dinesh O. Shah & P.A. Joshi. (2011) Sustained release of venlafaxine from venlafaxine–montmorillonite–polyvinylpyrrolidone composites. Applied Clay Science 51:1-2, pages 126-130.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.